Cargando…
BIGL: Biochemically Intuitive Generalized Loewe null model for prediction of the expected combined effect compatible with partial agonism and antagonism
Clinical efficacy regularly requires the combination of drugs. For an early estimation of the clinical value of (potentially many) combinations of pharmacologic compounds during discovery, the observed combination effect is typically compared to that expected under a null model. Mechanistic accuracy...
Autores principales: | Van der Borght, Koen, Tourny, Annelies, Bagdziunas, Rytis, Thas, Olivier, Nazarov, Maxim, Turner, Heather, Verbist, Bie, Ceulemans, Hugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738392/ https://www.ncbi.nlm.nih.gov/pubmed/29263342 http://dx.doi.org/10.1038/s41598-017-18068-5 |
Ejemplares similares
-
Agonism and Antagonism at the Insulin Receptor
por: Knudsen, Louise, et al.
Publicado: (2012) -
Analyzing magnetic bead QuantiGene® Plex 2.0 gene expression data in high throughput mode using QGprofiler
por: Verbist, Bie, et al.
Publicado: (2019) -
The future of EPAC-targeted therapies: agonism versus antagonism
por: Parnell, Euan, et al.
Publicado: (2015) -
Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms
por: Campbell, Jonathan E.
Publicado: (2020) -
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer
por: Singhal, Hari, et al.
Publicado: (2016)